miRagen Therapeutics, Inc. (NASDAQ: MGEN) announced today that it has appointed biotechnology industry veteran Arlene Morris to the role of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE